The company on Wednesday said that it is also working urgently to increase manufacturing capacity and supply by ramping up our own production network, as well as actively collaborating with external partners to maximize production of Actemra (Tocilizumab) wherever possible with the goal of increasing its availability.from Moneycontrol Business News https://ift.tt/3nAN8AP
Comments
Post a Comment